Stockscreener 앱 받기
11.55
10.60%
-1.37
시간 외 거래:
11.94
0.39
+3.38%
전일 마감가:
$12.92
열려 있는:
$12.94
하루 거래량:
525.62K
Relative Volume:
1.43
시가총액:
$388.01M
수익:
-
순이익/손실:
$-47.20M
주가수익비율:
-7.3788
EPS:
-1.5653
순현금흐름:
$-43.65M
1주 성능:
-23.46%
1개월 성능:
-3.35%
6개월 성능:
+2.67%
1년 성능:
+0.00%
1일 변동 폭
$10.71
$13.20
1주일 범위
$10.71
$15.19
52주 변동 폭
$4.8069
$27.50
Mbx Biosciences Inc Stock (MBX) Company Profile
명칭
Mbx Biosciences Inc
전화
(317) 989-3100
주소
11711 N. MERIDIAN STREET, CARMEL
MBX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MBX
Mbx Biosciences Inc
|
11.55 | 434.03M | 0 | -47.20M | -43.65M | -1.5653 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-15 | 재개 | Jefferies | Buy |
| 2025-08-05 | 개시 | Mizuho | Outperform |
| 2025-07-16 | 개시 | Oppenheimer | Outperform |
| 2025-04-10 | 개시 | Citizens JMP | Mkt Outperform |
| 2024-10-08 | 개시 | Guggenheim | Buy |
| 2024-10-08 | 개시 | JP Morgan | Overweight |
| 2024-10-08 | 개시 | Jefferies | Buy |
| 2024-10-08 | 개시 | Stifel | Buy |
모두보기
Mbx Biosciences Inc 주식(MBX)의 최신 뉴스
What’s the beta of MBX Biosciences Inc. stockJuly 2025 WrapUp & Community Shared Stock Ideas - خودرو بانک
Is MBX Biosciences Inc. exposed to political risk2025 Dividend Review & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
Is MBX Biosciences Inc. a strong growth stock2025 Sector Review & Verified Stock Trade Ideas - خودرو بانک
What’s the fair value of MBX Biosciences Inc. stockEarnings Recap Summary & Free Real-Time Volume Trigger Notifications - خودرو بانک
Is MBX Biosciences Inc. still worth holding after the dip2025 Short Interest & Target Return Focused Stock Picks - Newser
What’s the recovery path for long term holders of MBX Biosciences Inc.Market Growth Review & Free AI Powered Buy and Sell Recommendations - Newser
MBX Biosciences begins phase 1 trial of obesity treatment candidate By Investing.com - Investing.com Canada
What is MBX Biosciences Inc. s debt to equity ratioWeekly Trade Report & AI Forecasted Entry/Exit Points - خودرو بانک
Technical analysis overview for MBX Biosciences Inc. stockTrade Volume Report & Risk Controlled Daily Plans - Newser
What is MBX Biosciences Inc.’s book value per share2025 Breakouts & Breakdowns & High Accuracy Trade Signal Alerts - خودرو بانک
What high frequency data says about MBX Biosciences Inc.2025 Earnings Impact & Short-Term High Return Ideas - Newser
MBX Biosciences Doses First Participant in Phase 1 Trial of MBX 4291 for the Treatment of Obesity - MarketScreener
MBX Biosciences Begins Phase 1 Trial for Obesity Drug - TipRanks
MBX Biosciences begins phase 1 trial of obesity treatment candidate - Investing.com
First-Ever Monthly GLP-1/GIP Obesity Drug Enters Clinical Trials: MBX Biosciences' Novel Treatment Begins Testing - Stock Titan
Identifying reversal signals in MBX Biosciences Inc.Weekly Earnings Recap & AI Powered Buy/Sell Recommendations - Newser
Is MBX Biosciences Inc. forming a reversal patternPortfolio Gains Summary & Reliable Price Breakout Alerts - Newser
How to escape a deep drawdown in MBX Biosciences Inc.2025 Price Momentum & Weekly Hot Stock Watchlists - Newser
Momentum Traders Eye MBX Biosciences Inc. for Quick BouncePortfolio Profit Report & Risk Managed Trade Strategies - beatles.ru
Will MBX Biosciences Inc. rebound enough to break evenJuly 2025 Fed Impact & Low Drawdown Investment Ideas - Newser
How hedge fund analytics apply to MBX Biosciences Inc. stockJuly 2025 Technicals & AI Driven Price Forecasts - Newser
Risk adjusted return profile for MBX Biosciences Inc. analyzedDollar Strength & Community Driven Trade Alerts - Newser
Charles Schwab Investment Management Inc. Purchases 1,235 Shares of MBX Biosciences, Inc. $MBX - Defense World
Does MBX Biosciences Inc. meet Warren Buffett’s criteria2025 Macro Impact & Short-Term High Return Ideas - خودرو بانک
How does MBX Biosciences Inc. compare to its peersLayoff News & AI Driven Stock Price Forecasts - خودرو بانک
Smart tools for monitoring MBX Biosciences Inc.’s price action2025 Market Trends & Detailed Earnings Play Strategies - Newser
What technical models suggest about MBX Biosciences Inc.’s comeback2025 Retail Activity & Low Drawdown Trading Techniques - Newser
Why MBX Biosciences Inc. is moving todayEarnings Growth Report & Low Drawdown Investment Ideas - Newser
Buyout Rumor: Is MBX Biosciences Inc. trading at a discountJuly 2025 Chart Watch & Real-Time Stock Movement Alerts - خودرو بانک
Using portfolio simulators with MBX Biosciences Inc. includedJuly 2025 Highlights & Fast Entry High Yield Tips - Newser
MBX Biosciences Inc. stock daily chart insightsJuly 2025 Breakouts & Free Community Consensus Stock Picks - Newser
MBX Awaits Value-Creating Milestones, With Phase II Hypoparathyroidism Data Due Any Day - insights.citeline.com
Does MBX Biosciences Inc. show high probability of reboundWeekly Earnings Recap & Community Verified Trade Signals - Newser
Evaluating MBX Biosciences Inc. with trendline analysis2025 Market Overview & Long-Term Growth Stock Strategies - Newser
MBX Biosciences Inc. stock retracement – recovery analysis2025 Analyst Calls & Technical Confirmation Trade Alerts - Newser
MBX Biosciences Inc. stock prediction for this weekMarket Activity Recap & Long-Term Growth Portfolio Plans - Newser
How to recover losses in MBX Biosciences Inc. stockJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - Newser
Volatility clustering patterns for MBX Biosciences Inc.July 2025 Macro Moves & Long-Term Growth Stock Strategies - Newser
Mbx Biosciences Inc (MBX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Mbx Biosciences Inc 주식 (MBX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| GORDON CARL L | Director |
Feb 18 '25 |
Buy |
10.84 |
143,170 |
1,551,963 |
3,255,000 |
| GORDON CARL L | Director |
Feb 14 '25 |
Buy |
9.87 |
47,502 |
468,793 |
3,205,930 |
| ORBIMED ADVISORS LLC | Director |
Feb 18 '25 |
Buy |
10.84 |
143,170 |
1,551,963 |
3,255,000 |
| ORBIMED ADVISORS LLC | Director |
Feb 14 '25 |
Buy |
9.87 |
47,502 |
468,793 |
3,205,930 |
| Hawryluk P. Kent | President & CEO |
Feb 04 '25 |
Buy |
10.69 |
50,000 |
534,500 |
448,277 |
| Mathers Edward T | Director |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| BASKETT FOREST | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| Behbahani Ali | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| Chang Carmen | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| Florence Anthony A. Jr. | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
1.40%
자본화:
|
볼륨(24시간):